Home › Funds › Renaissance Technologies › ALKS

Renaissance Technologies position in ALKS

ALKERMES PLC · Health Care

Renaissance Technologies reported holding 6,493,828 shares of ALKS (ALKERMES PLC) in its Q3 2026 13F filing — a position valued at US$263.1M, representing 0.36% of its reported portfolio and ranking #39 among its reported holdings. Renaissance Technologies has disclosed ALKS holdings in 45 of the last 55 reported quarters, going back to Q1 2013.

Latest position (Q3 2026)6.49M sh
Reported value held$263.13M
Portfolio Weight0.36%
First reportedQ1 2013
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Renaissance Technologies's ALKS position evolved

Renaissance Technologies first disclosed a stake in ALKS in Q1 2013 at 117,800 shares (US$2.8M). The position peaked in Q2 2026 at 6,460,928 shares, worth US$338.5M. Across 45 filings, Renaissance Technologies increased the stake 24 time(s), trimmed it 16 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 6,493,828 shares valued at US$263.1M — an increase of 32,900 shares quarter over quarter.. Notable position changes include a 575% increase in Q2 2013, a 303% increase in Q2 2014, a 211% increase in Q1 2015.

Quarter by quarter

QuarterSharesValueChange
Q1 2013 117.80K $2.79M New
Q2 2013 794.69K $22.79M Add
Q3 2013 661.69K $22.25M Reduce
Q4 2013 505.59K $20.56M Reduce
Q1 2014 53.31K $2.35M Reduce
Q2 2014 214.69K $10.80M Add
Q3 2014 155.79K $6.68M Reduce
Q4 2014 63.99K $3.75M Reduce
Q1 2015 198.69K $12.11M Add
Q2 2015 229.29K $14.75M Add
Q4 2015 26.29K $2.09M New
Q1 2017 124.89K $7.31M New
Q1 2018 114.79K $6.65M New
Q4 2018 794.40K $23.44M New
Q1 2019 1.65M $60.13M Add
Q2 2019 3.95M $89.05M Add
Q3 2019 4.90M $95.62M Add
Q4 2019 6.64M $135.39M Add
Q1 2020 7.18M $103.55M Add
Q2 2020 7.14M $138.46M Reduce
Q3 2020 6.78M $112.41M Reduce
Q4 2020 6.96M $138.76M Add
Q1 2021 6.07M $113.30M Reduce
Q2 2021 5.28M $129.43M Reduce
Q3 2021 4.74M $146.32M Reduce
Q4 2021 4.81M $111.90M Add
Q1 2022 4.87M $128.08M Add
Q2 2022 5.32M $158.56M Add
Q3 2022 5.56M $124.07M Add
Q4 2022 5.64M $147.49M Add
Q1 2023 4.94M $139.23M Reduce
Q2 2023 5.17M $161.71M Add
Q3 2023 6.12M $171.31M Add
Q4 2023 6.05M $167.81M Reduce
Q1 2024 5.89M $159.37M Reduce
Q2 2024 5.48M $132.16M Reduce
Q3 2024 5.42M $151.73M Reduce
Q4 2024 5.48M $157.57M Add
Q1 2025 5.74M $189.50M Add
Q2 2025 5.81M $166.23M Add
Q3 2025 6.29M $188.78M Add
Q4 2025 6.67M $186.57M Add
Q1 2026 6.16M $217.83M Reduce
Q2 2026 6.46M $338.52M Add
Q3 2026 6.49M $263.13M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ALKS and 13F data

ALKS (ALKERMES PLC) is a Health Care company. 37 other funds we track also report a position in ALKS — the largest reported positions include BAKER BROS. ADVISORS LP (US$524.6M), Deep Track Capital, LP (US$209.6M), Commodore Capital LP (US$157.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ALKS

All ALKS fund holders →

FAQ

How long has Renaissance Technologies held ALKS?

Renaissance Technologies has disclosed ALKS holdings in 45 of the last 55 reported quarters, going back to Q1 2013.

What is Renaissance Technologies's current position in ALKS?

As of Q3 2026, Renaissance Technologies holds 6.49M shares of ALKS (ALKERMES PLC), valued at $263.13M, representing 0.36% of its reported portfolio and ranking #39.

Has Renaissance Technologies been buying or selling ALKS?

In the latest 13F filing (Q3 2026), Renaissance Technologies increased its position in ALKS. The position peaked in Q2 2026 at 6.46M shares.

Which other funds hold ALKS?

Other major institutional holders of ALKS include BAKER BROS. ADVISORS LP, Deep Track Capital, LP, Commodore Capital LP, among 37 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.